Capital Flow Monitor · Sponsors · CIK 2097084
Medici Therapeutics, Inc.
230 COMMONWEALTH AVENUE, BOSTON, MA, 02116 · 407-733-2808
Biotechnology · Corporation· inc. DELAWARE true 2021
Fit score
—
Offering
$14.8M
Sold
$14.8M
% sold
100.0%
Investors
11
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-04 | D ·current | 506(b) | $14.8M | $14.8M | 100.0% | 11 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Denitsa Milanova — Executive Officer / Director, Boston, MA
-
David Thompson — Executive Officer, Boston, MA
23 other raises
- TI Dental Fund II, LP $8.5M of $10.0M · 85.4%
- PGIM Lending Fund (Foxtrot) (Rated Feeder Fund), L.P. $0 of —
- SIOX, LLC $340K of $500K · 68.0%
- CIM-BGV Affordable Housing Impact Fund I, L.P. $95.0M of —
- TI Nexus CPA Fund, LP $0 of $10.0M · 0.0%
- CIM Urban Income Investments Parallel - 2, L.P. $1.57B of —
- CIM Commercial Lending REIT $1.9M of $2.5B · 0.1%
- CIM Opportunity Zone Fund, L.P. $2.22B of —
- Ulrich Media Inc. $0 of $100.0M · 0.0%
- CIM UII Onshore, L.P. $1.57B of —
- CIM UII Onshore EE, L.P. $325K of —
- Osteal Therapeutics, Inc. $15.6M of $26.7M · 58.4%
- CMMTP-2, L.P. $1.27B of —
- CMMTP-1, L.P. $1.27B of —
- CMMT Partners, L.P. $1.27B of —
- Rise Private Credit Fund, LLC $5.5M of $27.8M · 19.9%
- TI Midwest Fund 5, LP $1.8M of $10.0M · 18.0%
- North Haven Capital Partners VIII-A LP $627.9M of —
- North Haven Capital Partners VIII U.S. Wealth Management Partners LP $865.1M of —
- North Haven Capital Partners VIII SCSp $493.0M of —
- North Haven Capital Partners VIII Non-U.S. Wealth Management Partners LP $411.9M of —
- North Haven Capital Partners VIII LP $673.2M of —
- MSCP VIII Employees LP $57.5M of —
- Nicholas P. Restifo — Executive Officer, Boston, MA
- Matthew Rabinowitz — Director, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.